Research shows that a protein called LGR4 in liver blood vessel cells protects against fatty liver disease. When scientists removed this protein from mice fed a high-fat diet, the animals developed significantly more liver fat, gained more weight, and had higher blood sugar and triglyceride levels. According to Gram Research analysis, this discovery identifies LGR4 as a key regulator of liver health and could lead to new treatments for metabolic dysfunction-associated steatotic liver disease, the most common liver disease worldwide.
Scientists discovered that a protein called LGR4 in the blood vessels of your liver plays a crucial role in preventing fat from building up in liver cells. When researchers removed this protein from the blood vessel cells in mice, the animals gained more weight, had higher blood sugar and fat levels, and developed more liver fat. According to Gram Research analysis, this finding helps explain how liver disease develops and could lead to new treatments for a common condition called metabolic dysfunction-associated steatotic liver disease, which affects millions of people worldwide.
Key Statistics
A 2026 research study in laboratory mice found that removing the LGR4 protein from liver blood vessel cells resulted in exacerbated hepatic steatosis and increased expression of fat-uptake genes CD36 and OLR1 compared to control mice fed a Western diet.
Male mice lacking the LGR4 protein in their blood vessel cells exhibited increased weight gain, elevated fasting blood glucose, and higher plasma triglycerides compared to normal mice, according to the 2026 study published in Life Sciences.
The 2026 research demonstrated that loss of EC-restricted LGR4 in mice promoted expression of apoptotic markers, suppressed AMPK activation, and enhanced liver sinusoidal endothelial cell capillarization, indicating multiple mechanisms linking LGR4 to liver fat accumulation.
The Quick Take
- What they studied: Whether a protein called LGR4 in liver blood vessel cells helps protect against fatty liver disease
- Who participated: Laboratory mice, both male and female, that were genetically modified to lack the LGR4 protein in their blood vessel cells. The mice were fed a high-fat diet similar to Western eating patterns.
- Key finding: Male mice without the LGR4 protein in their blood vessels gained more weight, had higher blood sugar and triglycerides, and developed significantly more fat in their livers compared to normal mice
- What it means for you: This research suggests that keeping LGR4 protein working properly in liver blood vessels may be important for preventing fatty liver disease. However, this is early-stage research in mice, so more studies are needed before any treatments can be developed for humans.
The Research Details
Researchers created special laboratory mice that lacked the LGR4 protein specifically in their blood vessel cells. They compared these modified mice to normal control mice and fed both groups a high-fat diet similar to what many people eat. Over time, they measured how much weight the mice gained, checked their blood sugar and fat levels, and examined their liver tissue under a microscope to see how much fat had accumulated.
The scientists used several techniques to understand what was happening inside the liver. They looked at which genes were turned on or off, examined the structure of the liver blood vessels, and measured markers of inflammation and cell death. This allowed them to not only see that the mice developed more liver fat, but also understand some of the biological reasons why this happened.
Both male and female mice were studied to see if the LGR4 protein worked the same way in both sexes. The researchers also looked for signs of liver scarring, which is a more serious form of liver damage, though they did not find significant differences in this area.
Understanding which proteins control liver health is important because fatty liver disease is now the most common liver disease worldwide. By identifying LGR4 as a protective protein, scientists can better understand how the disease develops and potentially create new medicines to prevent or treat it. This research is particularly valuable because it focuses on the blood vessel cells in the liver, which had not been thoroughly studied before in relation to fatty liver disease.
This study was conducted in a controlled laboratory setting using genetically modified mice, which allows researchers to study one specific protein without interference from other factors. The use of both male and female mice strengthens the findings. However, because this research was done in mice rather than humans, the results may not directly apply to people. The study examined multiple markers of liver health and metabolic function, which makes the findings more reliable. The specific genetic modification technique used is well-established in scientific research.
What the Results Show
When the LGR4 protein was removed from liver blood vessel cells, male mice showed clear signs of metabolic problems. These mice gained significantly more weight and accumulated more body fat compared to normal mice eating the same diet. Their fasting blood sugar levels were higher, and they had elevated triglycerides, which are a type of fat in the blood.
Most importantly, the livers of these modified mice contained much more fat than the livers of normal mice. The researchers also found that genes related to fat uptake, specifically CD36 and OLR1, were more active in the livers of mice lacking LGR4. This suggests that without LGR4, the liver cells are taking in and storing more fat.
The researchers discovered that losing the LGR4 protein caused changes in the structure of liver blood vessels. Normally, liver blood vessels have special properties that help them function properly. When LGR4 was removed, the blood vessels became more rigid and less flexible, a process called capillarization. This structural change was accompanied by increased inflammation in the liver.
At the cellular level, mice without LGR4 showed increased markers of cell death and reduced activation of a protein called AMPK, which normally helps cells burn fat for energy. Female mice also developed more liver fat when LGR4 was removed, though the study focused more on male mice.
The study did not find significant differences in liver scarring between the two groups of mice, suggesting that LGR4 loss primarily affects fat accumulation rather than more advanced liver damage. The changes in liver blood vessel structure appeared to be a key mechanism linking LGR4 loss to increased liver fat. The increased inflammation observed in mice lacking LGR4 may contribute to further liver damage over time.
Previous research showed that removing LGR4 from all cells in the body actually improved how mice handled metabolism and weight. This new study reveals that the story is more complicated: removing LGR4 specifically from blood vessel cells has the opposite effect and makes metabolic problems worse. This demonstrates that different cell types in the body use LGR4 for different purposes. The findings also add to growing evidence that liver blood vessel cells play a more important role in fatty liver disease than scientists previously thought.
This research was conducted entirely in laboratory mice, so the results may not directly translate to humans. The study did not examine what happens over very long periods of time or whether the effects change as mice age. The researchers did not test any potential treatments to reverse the effects of LGR4 loss. The study focused more extensively on male mice, so the findings in female mice are less detailed. Additionally, the study examined only one specific genetic modification and did not test whether increasing LGR4 levels would have protective effects.
The Bottom Line
Based on this research, there are currently no specific recommendations for people to change their behavior, as this is early-stage laboratory research. However, the findings suggest that future treatments targeting the LGR4 protein or related pathways could potentially help prevent or treat fatty liver disease. People concerned about liver health should focus on established preventive measures: maintaining a healthy weight, eating a balanced diet low in processed foods, limiting alcohol consumption, and exercising regularly. These steps are proven to reduce the risk of fatty liver disease.
This research is most relevant to people at risk for fatty liver disease, including those who are overweight, have type 2 diabetes, or have high cholesterol. Scientists and pharmaceutical companies developing new treatments for liver disease should pay close attention to these findings. People with existing liver disease should continue following their doctor’s recommendations while staying informed about emerging research. This research is less immediately relevant to people with healthy livers and normal metabolism, though understanding liver disease prevention benefits everyone.
Since this is basic research in mice, it will likely take several years before any human treatments based on these findings could be developed and tested. Researchers will first need to confirm these findings in additional studies and then develop drugs that can safely target LGR4 in humans. Clinical trials in people would follow, which typically take several more years. People should not expect any new treatments based on this research to be available in the near term.
Frequently Asked Questions
What is LGR4 and why does it matter for liver health?
LGR4 is a protein found in liver blood vessel cells that helps protect against fatty liver disease. When this protein is working properly, it helps prevent fat from accumulating in the liver. Research shows that mice without functional LGR4 in their blood vessels developed significantly more liver fat and metabolic problems.
Can I test my LGR4 levels to see if I’m at risk for fatty liver disease?
Currently, LGR4 testing is not available for patients outside of research settings. This is early-stage research in mice. If you’re concerned about fatty liver disease risk, talk to your doctor about standard tests like liver function tests and ultrasound imaging, which can detect fatty liver disease.
How does a Western diet contribute to the liver problems seen in this study?
The Western diet is high in fat and calories, which forces the liver to process and store excess fat. In mice lacking LGR4, this high-fat diet triggered severe fat accumulation in the liver because the protective LGR4 protein was not available to prevent it. This mimics how human fatty liver disease develops.
Will this research lead to new treatments for fatty liver disease?
This research identifies LGR4 as a potential drug target, but developing treatments takes many years. Scientists must first confirm these findings in additional studies, then develop safe drugs targeting LGR4, and finally test them in human clinical trials. New treatments based on this research are likely several years away.
Does this research apply to people or just mice?
This research was conducted in laboratory mice, so results may not directly apply to humans. However, the findings provide important clues about how fatty liver disease develops and suggest new directions for human treatment research. More studies are needed to confirm whether LGR4 works the same way in people.
Want to Apply This Research?
- Track weekly weight, waist circumference, and energy levels. Also monitor dietary fat intake and exercise duration to correlate lifestyle factors with metabolic health markers.
- Users can log daily meals to monitor fat and calorie intake, set exercise goals to improve metabolic fitness, and track weight trends over time. The app could provide alerts when users approach high-fat diet patterns similar to those used in the study.
- Establish a baseline of current weight and metabolic markers, then monitor changes monthly. Track consistency with healthy eating and exercise habits. Share trends with healthcare providers during regular checkups to assess overall metabolic health and liver function.
This research was conducted in laboratory mice and has not been tested in humans. The findings are preliminary and should not be interpreted as medical advice or as a basis for treatment decisions. Fatty liver disease is a serious condition that requires professional medical evaluation and management. If you have concerns about liver health, fatty liver disease, or metabolic dysfunction, consult with a qualified healthcare provider. Do not attempt to self-diagnose or self-treat based on this research. Any future treatments based on LGR4 targeting would require extensive human clinical trials and regulatory approval before becoming available to patients.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.